Synthesis and biological evaluation of novel salicylidene uracils: Cytotoxic activity on human cancer cell lines and inhibitory action on enzymatic activity
Open Access
- 30 October 2023
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 357 (1) , e2300374
Abstract
A series of salicylidene uracil (1–18) derived from 5‐aminouracil and substituted salicylaldehydes were analyzed for cytotoxic activity and enzyme inhibitory potency. Nine out of eighteen derivatives (6–8, 10, 12–15, 18) are novel molecules synthesized for the first time in this work, and other derivatives were previously synthesized by our group. The compounds were characterized by Proton nuclear magnetic resonance, carbon nuclear magnetic resonance, fourier transform infrared spectroscopy, and elemental analysis. All compounds were tested for their in vitro cytotoxicity against PC‐3 (human prostate adenocarcinoma), A549 (human alveolar adenocarcinoma), and SHSY‐5Y (human neuroblastoma) cancer cell lines and the nontumorigenic HEK293 (human embryonic kidney cells) cell line. The 3,5‐di‐tert‐butylsalicylaldehyde derived compound (8) was toxic to PC‐3 human prostate adenocarcinoma cells, showing a promising IC50 value at 7.05 ± 0.76 μM. The present study also aimed to evaluate the inhibitory effects of the compounds against several key enzymes, namely carbonic anhydrase I and II (CA I and CA II), acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and glutathione reductase (GR), which are implicated in various global disorders, such as Alzheimer's disease, epilepsy, cancer, malaria, diabetes, and glaucoma. The inhibitory profiles of the tested compounds were assessed by determining their Ki values, which ranged from 2.96 to 9.24 nM for AChE, 3.78 to 12.57 nM for BChE, 8.42 to 25.74 nM for CA I, 7.24 to 19.74 nM for CA II, and 0.541 to 1.124 μM for GR. Molecular docking studies were also performed for all compounds. Most derivatives exhibited much more effective inhibitory action compared with clinically used standards. Thus, our findings indicate that the salicylidene derivatives presented in this study are promising drug candidates that need further evaluation.Keywords
This publication has 47 references indexed in Scilit:
- Quantitative comparison of protein dynamics in live cells and in vitro by in-cell 19F-NMRChemical Communications, 2013
- Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important LigandsJournal of Medicinal Chemistry, 2012
- α-Carbonic anhydrases are sulfatases with cyclic diol monosulfate estersJournal of Enzyme Inhibition and Medicinal Chemistry, 2011
- Pyrimidine based highly sensitive fluorescent receptor for Al3+ showing dual signalling mechanismOrganic & Biomolecular Chemistry, 2010
- Isosorbide-2-benzyl Carbamate-5-salicylate, A Peripheral Anionic Site Binding Subnanomolar Selective Butyrylcholinesterase InhibitorJournal of Medicinal Chemistry, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Enzymology of Purine and Pyrimidine Antimetabolites Used in the Treatment of CancerChemical Reviews, 2009
- Synthesis, structure and biological activity of a new and efficient Cd(II)–uracil derivative complex system for cleavage of DNAJBIC Journal of Biological Inorganic Chemistry, 2005
- Dithiol Proteins as Guardians of the Intracellular Redox Milieu in Parasites: Old and New Drug Targets in Trypanosomes and Malaria‐Causing PlasmodiaAngewandte Chemie International Edition, 2005
- THE HISTOCHEMICAL LOCALIZATION OF ACETYLCHOLINESTERASE IN THE FINE STRUCTURE OF NEUROMUSCULAR JUNCTIONS OF MOUSE AND HUMAN INTERCOSTAL MUSCLEJournal of Histochemistry & Cytochemistry, 1961